1 Min Read
Feb 7 (Reuters) - Tapimmune Inc:
* Tapimmune expands intellectual property on Polystart platform for use in next-generation T-cell vaccines
* Term of patent extends to March 17, 2035 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.